NanoString Technologies | NSTG - سود عملیاتی



سود عملیاتی تغییر دادن تاریخ
Agilent USD 353M 90M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Bio Techne USD 54.46M 6.8M 2025-12
Bio-Rad Laboratories USD 63.9M 13.2M 2025-09
Bruker USD 76.3M 7.6M 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Danaher USD 1.5B 348M 2025-12
Exact Sciences USD -25M 22.85M 2025-09
Hologic USD 237M 16M 2025-12
Illumina USD 256M 6M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -23.3M 10.8M 2025-09
Pacific Biosciences Of California USD -64.08M 111.77M 2024-09
Repligen USD 19.97M 7.29M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Standard Biotools USD -23.47M 230K 2025-09
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Waters USD 270.52M 78.4M 2025-12